Elizabeth A. Fagan

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure

Achilles A. Demetriou, Robert S. Brown, Ronald W. Busuttil et al. · Annals of Surgery · 2004 · 668 citations · Full text

Medicine, Internal Medicine, Hepatology +14

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis

Steven D. Nathan, Carlo Albera, Williamson Z. Bradford et al. · Thorax · 2016 · 179 citations · Full text

Health Professions, Pharmacotherapy, Comparative Effectiveness Research +13

Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis

William F. Carman, Elizabeth A. Fagan, Stephanos J. Hadziyannis et al. · Hepatology · 1991 · 172 citations

Life Sciences, Genetics, Molecular Genetics +14

Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function

Carlo Albera, Ulrich Costabel, Elizabeth A. Fagan et al. · European Respiratory Journal · 2016 · 165 citations · Full text

Health Professions, Pharmacotherapy, Pulmonary Function Testing +14